Visceral and subcutaneous adiposity and brachial artery vasodilator function

Obesity

Volumn 17, Issue 11, 2009, Pages 2054-2059

  Parikh, Nisha I ^a,g   Keyes, Michelle J ^a,b   Larson, Martin G ^a,b   Pou, Karla M ^c   Hamburg, Naomi M ^b   Vita, Joseph A ^b   O'Donnell, Christopher J ^a,d,e   Vasan, Ramachandran S ^a,b   Mitchell, Gary F ^f   Hoffmann, Udo ^d   Fox, Caroline S ^a,c,e   Benjamin, Emelia J ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f CARDIOVASCULAR ENGINEERING INC   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL FAT; ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMODYNAMICS; HISTOLOGY; HUMAN; MALE; MECHANICAL STRESS; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIUM; VASODILATATION; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADIPOSITY; BODY MASS INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; STRESS, MECHANICAL; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED; VASODILATION; WAIST CIRCUMFERENCE;

EID: 70350566626     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.60     Document Type: Article

References (38)

1. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869. (Pubitemid 34940825)
2. Gokce N, Keaney JF Jr, Hunter LM et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002;105:1567-1572.
3. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007;115: 2390-2397.
4. Arcaro G, Zamboni M, Rossi L et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999;23:936-942.
5. Steinberg HO, Chaker H, Leaming R et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-2610.
6. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001;88:1264-1269.
7. Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848.
8. Chiba Y, Saitoh S, Takagi S et al. Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertens Res 2007;30:229-236.
9. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007;27:996-1003.
10. Hayashi T, Boyko EJ, Leonetti DL et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation 2003;108:1718-1723.
11. Benjamin EJ, Larson MG, Keyes MJ et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham heart study. Circulation 2004;109:613-619.
12. Maurovich-Horvat P, Massaro J, Fox CS et al. Comparison of anthropometric, area-and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 2007;31:500-506.
13. Mitchell GF, Parise H, Vita JA et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 2004;44:134-139.
14. Jang Y, Kim O Y, Ryu HJ et al. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J Lipid Res 2003;44:2356-2364.
15. Hashimoto M, Akishita M, Eto M et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 1998;22:477-484.
16. Lind L, Johansson L, Hulthe J, von Below C, Ahlstrom H. Vasodilation and visceral fat in elderly subjects The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2007;194:e64-e71.
17. Juonala M, Viikari JS, Laitinen T et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004;110: 2918-2923. (Pubitemid 39473618)
18. Vega GL, Adams-Huet B, Peshock R et al. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006;91:4459-4466.
19. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
20. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 2004;89:4206-4210.
21. Tulloch-Reid MK, Hanson RL, Sebring NG et al. Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in African Americans. Obes Res 2004;12:1352-1359.
22. Wagenknecht LE, Langefeld CD, Scherzinger AL. et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003;52:2490-2496.
23. Hayashi T, Boyko EJ, Leonetti DL et al. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 2003;26:650-655.
24. Nicklas BJ, Penninx BW, Ryan AS et al. Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care 2003;26:1413-1420.
25. Vohl MC, Sladek R, Robitaille J et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 2004;12:1217-1222.
26. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
27. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
28. Park KG, Park KS, Kim MJ et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-142.
29. Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000;1500:88-96.
30. Kathiresan S, Gona P, Larson MG et al. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation 2006;113:938-945.
31. Verma S, Li SH, Badiwala MV et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002;105:1890-1896.
32. Pasceri V, Willerson J T, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-2168.
33. Torigoe M, Matsui H, Ogawa Y et al. Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin Endocrinol (Oxf) 2007;67:276-281.
34. Bahia L, Aguiar LG, Villela N et al. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 2006;61:433-440.
35. Lam PM, Yim SF, Chung TK, Haines C. Serum vascular endothelial growth factor as a possible indicator of arterial reactivity in postmenopausal women. Gynecol Endocrinol 2006;22:460-464.
36. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005;365:1817-1820.
37. Chinen I, Shimabukuro M, Yamakawa K et al. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 2007;148:160-165.
38. Kuk JL, Church TS, Blair SN, Ross R. Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 2006;29:679-684